European Union

Estimated Prevalence of Amphetamine and Methamphetamine Use in the EU

"It is estimated that 12.3 million adults in the European Union (aged 15-64), or 3.7% of this age group, have used amphetamines at least once in their lifetime. Figures from the 26 countries that report a survey between 2014 and 2018 suggest that 1.4 million (1.2%) young adults (aged 15-34) used amphetamines during the last year, with national prevalence estimates ranging from zero in Portugal to 3% in Finland (Figure 13). The available data suggest that over the longer term, prevalence levels have been relatively stable in most countries.

Prevalence of Heroin and Illegal Opioid Use in the EU

"The prevalence of high-risk opioid use among adults (15-64) is estimated at 0.4 % of the EU population, equivalent to 1.3 million high-risk opioid users in 2018. At national level, prevalence estimates of high-risk opioid use range from less than 1 to more than 8 users per 1 000 population aged 15-64 (Figure 27). The five most populous countries in the European Union (Germany, Spain, France, Italy, United Kingdom), account for three quarters (75 %) of this estimate.

Estimated Prevalence of Cannabis Use Among Young Adults in the EU

"It is estimated that 90.2 million adults in the European Union (aged 15-64), or 27.2 % of this age group, have used cannabis at least once in their lifetime. Around 15 % (18.0 million) of young adults (aged 15-34) report using cannabis in the last year, with males being typically twice as likely to report use than females. Among the 27 countries that undertook surveys between 2014 and 2018, considerable variation exists, with last year use rates among young adults ranging from 3.5 % in Hungary to 21.8 % in France.

Monitoring of Spice and New Psychoactive Substances

Monitoring of Spice and New Psychoactive Substances: "A dramatic online snapshot of the Spice phenomenon as an emerging trend has been recently given by an important web mapping program, the Psychonaut Web Mapping Project, a European Commission-funded project involving researchers from seven European countries (Belgium, Finland, Germany, Italy, Norway, Spain, and UK), which aims to develop a web scanning system to identify newly marketed psychoactive compounds, and their combinations (e.g., ketamine and Spice, cannabis and Spice), on the basis of the information available on the Internet (Psych

Hemp Cultivation in EU

"The survey covers the harvest of 2013, related to a total cultivation area of 15,700 ha. The first figure shows the development of the cultivation area since 1993. Between 1993 and 1996 the cultivation of industrial hemp was legalised in most of the member states, others followed later. In 2011 the cultivation area decreased to its lowest value since 1994 (ca. 8,000 ha), but increased in 2012, 2013 and 2014, to finally reach 25,000 ha in 2015. In 2016 a further increase is expected. The main cultivation member states are France and The Netherlands.

Harm Reduction Defined

"Harm reduction encompasses interventions, programmes and policies that seek to reduce the health, social and economic harms of drug use to individuals, communities and societies. A core principle of harm reduction is the development of pragmatic responses to dealing with drug use through a hierarchy of intervention goals that place primary emphasis on reducing the health-related harms of continued drug use (Des Jarlais, 1995; Lenton and Single, 2004).

"Spice" and Other Herbal Highs

"‘Spice’ and other ‘herbal’ products are often referred to as ‘legal highs’ or ‘herbal highs’, in reference to their legal status and purported natural herbal make-up (McLachlan, 2009; Lindigkeit et al., 2009; Zimmermann et al., 2009). However, albeit not controlled, it appears that most of the ingredients listed on the packaging are actually not present in the ‘Spice’ products and it is seems likely that the psychoactive effects reported are most probably due to added synthetic cannabinoids, which are not shown on the label.

Drug Consumption Rooms in Operation in the EU

"Breaking this down further, as of February 2017 there are: 31 facilities in 25 cities in the Netherlands; 24 in 15 cities in Germany; five in four cities in Denmark 13 in seven cities in Spain; two in two cities in Norway; two in two cities in France; and one in Luxembourg (Luxembourg is preparing to open a second facility in 2018); and 12 in eight cities in Switzerland. In Slovenia following a change in the penal code that created an enabling environment for the opening of supervised consumption facilities, a planned pilot project is pending.

Pages